Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02451254 |
Date of registration:
|
19/05/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Coagulation Activity and Thrombogenesis in Patients With Atrial Fibrillation
|
Scientific title:
|
Coagulation Activity and Thrombogenesis in Patients With Atrial Fibrillation |
Date of first enrolment:
|
December 1, 2015 |
Target sample size:
|
60 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02451254 |
Study type:
|
Interventional |
Study design:
|
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Ehud Chorin, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Tel Aviv Medical Center |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. AF patients from cardiology department in our institution electively admitted for
circumferential ablation of the pulmonary veins.
2. Control - patients from cardiology department in our institution electively admitted
for SVT ablation.
Exclusion Criteria:
1.Intra- and extra-cardiac shunts
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Atrial Fibrillation
|
Intervention(s)
|
Procedure: circumferential ablation
|
Device: SVT ablation
|
Primary Outcome(s)
|
Thrombotic biomarkers in AF patients
[Time Frame: 12 months]
|
Secondary ID(s)
|
TASMC-15-EC-0142-15-CTIL
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|